Ketamine and Propofol NeuroImaging
Trial statusRecruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexAll
Age18-59
SponsorKeith M Vogt
About this trial
This is a multi-visit which will collect MRI (pictures of the brain) and EEG (brain waves) data to determine changes in brain connectivity and brain activity for memory formation and pain perception while receiving the commonly-used anesthetic agents ketamine and propofol, both alone and in combination.
Eligibility criteria
Qualifiers
have none of the specific
Disqualifiers
have a valid email address and valid phone number throughout the study
free from any non-MRI compatible implants
are pregnant or attempting to conceive
body mass index (BMI) > 35
Trial design
Treatments tested in this trial
- Propofol
- Ketamine
- Peripheral Nerve Stimulation
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Keith M Vogt
Lead sponsor
University of Pittsburgh
Sponsor institution
National Institute of General Medical Sciences (NIGMS)
Collaborator
Source ClinicalTrials.gov